MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2018 International Congress

October 5-9, 2018. Hong Kong. Abstracts are presented on the 6th, 7th, and 8th.

View by Title View Sessions
View by Date

Monday, October 8, 2018

1:15pm-2:45pm
Frontal midline theta activity is reduced during cognitive control in Parkinson’s disease

A. Singh, S. Richardson, N. Narayanan, J. Cavanagh (Iowa City, IA, USA)

Parkinson's Disease: Cognition  ·  Hall 3FG
1:15pm-2:45pm
Frontal-subcortical cognitive impairments in Parkinson’s patients with freezing of gait

J. Garcia-Caldentey, MA. Prats-Sedano, E. Estelrich-Peyret, PJ. Garcia-Ruiz (Palma de Mallorca, Spain)

Parkinson's Disease: Pathophysiology  ·  Hall 3FG
1:15pm-2:45pm
Full sequencing and haplotype analysis reveals LRRK2 protective haplotype in REM sleep behavior disorder

B. Ouled Amar-Bencheikh, J. Ruskey, I. Arnulf, Y. Dauvilliers, C. Charley Monaca, V. Cochen De-Cock, JF. Gagnon, D. Spiegelman, M. Hu, B. Högl, A. Stefani, L. Ferini-Strambi, G. Plazzi, E. Antelmi, P. Young, A. Heidbreder, B. Mollenhauer, F. Sixel-Döring, C. Trenkwalder, W. Oertel, J. Montplaisir, R. Postuma, G. Rouleau, Z. Gan-Or (Montreal, QC, Canada)

Parkinson's Disease: Genetics  ·  Hall 3FG
1:15pm-2:45pm
Functional Balance and Neuromuscular Strength Difficulties Like Fracture Predictors in a Parkinsonian Population

L. Leandro, C. Moreira, H. Teive (Curitiba, Brazil)

Rating Scales  ·  Hall 3FG
1:15pm-2:45pm
Functional connectivity changes in relation to dopaminergic decline in Parkinson’s over time: A resting-state fMRI and 11C-PE2I PET imaging study

W. Li, N. Lao-Kaim, A. Roussakis, A. Martín-Bastida, N. Valle-Guzman, G. Paul, E. Soreq, R. Daws, T. Foltynie, R. Barker, A. Hampshire, P. Piccini (London, United Kingdom)

Parkinson's Disease: Neuroimaging And Neurophysiology  ·  Hall 3FG
1:15pm-2:45pm
FuRST2.0: Development of a modified functional rating scale for use in premanifest and early-manifest Huntington’s disease

R. Fuller, P. Feigenbaum, C. Fitzer-Attas, N. La Pelle, S. Luo, C. Sampaio, G. Stebbins (Princeton, NJ, USA)

Rating Scales  ·  Hall 3FG
1:15pm-2:45pm
Further insights into excitatory-inhibitory balance of the primary motor cortex in Parkinson’s disease: A triple-pulse stimulation study

Y. Shirota, Y. Terao, Y. Ugawa, R. Hanajima (Tokyo, Japan)

Parkinson's Disease: Neuroimaging And Neurophysiology  ·  Hall 3FG
1:15pm-2:45pm
Gastrointestinal Symptoms and Enteric Nerve Dysfunction in A53T Mice

R. McQuade, P. Rajasekhar, S. Diwakarla, R. Constable, D. Poole, J. Berger, D. Finkelstein, J. Furness (Melbourne, Australia)

Parkinson's Disease: Non-Motor Symptoms  ·  Hall 3FG
1:15pm-2:45pm
Gaucher’s disease (GD) and Parkinsonism: An analysis from patients to relatives

I. Trezzi, E. Monfrini, E. Cassinerio, I. Motta, F. Nascimbeni, F. Carubbi, N. Bresolin, G. Comi, M. Cappelllini, A. Di Fonzo (Milan, Italy)

Parkinson's Disease: Genetics  ·  Hall 3FG
1:15pm-2:45pm
GBA haploinsufficiency accelerated alpha synuclein pathology with altered lipid metabolism in a premotor model of Parkinson’s disease

H. Yamakado, M. Ikuno, H. Akiyama, L. Parajuli, K. Taguchi, J. Hara, N. Uemura, Y. Hatanaka, K. Higaki, M. Tanaka, M. Koike, Y. Hirabayashi, R. Takahashi (Kyoto, Japan)

Parkinson's Disease: Pathophysiology  ·  Hall 3FG
  • «Previous Page
  • 1
  • …
  • 22
  • 23
  • 24
  • 25
  • 26
  • …
  • 59
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley